Do you have the same question? Follow this Question
Oct 01, 2025 - 04:46 AM
We’ve provided several answers to questions related to Addyi (Flibanserin) , see some other helpful Q&A related to this product.
Question: Who can use this medication?
Answer: This medication is approved for premenopausal women diagnosed with HSDD. It is not intended for use in men or postmenopausal women, ensuring it is used in the population where it is proven to be effective and safe.
Question: What is the KEGG code for this medication?
Answer: The KEGG code is D02577. KEGG (Kyoto Encyclopedia of Genes and Genomes) provides information on biological pathways and drug actions, supporting research and clinical decision-making.
Question: What is the DrugBank ID for flibanserin?
Answer: The DrugBank ID is DB04908. DrugBank provides comprehensive information about drugs and their mechanisms, which is valuable for both clinicians and researchers.
Question: How is this medication supplied?
Answer: This medication is supplied as 100mg tablets, with a package containing 30 tablets (total 500mg). This packaging supports a full month of therapy at the recommended daily dose, which is convenient for ongoing treatment.
